Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies have?
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies has 73 citations in the OpenAlex counts ScholarIQ stores.
When was Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies published?
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies has 2025 year in the ScholarIQ index.
What is the open-access status of Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies?
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies has closed oa status in the ScholarIQ index.
What is the DOI of Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies?
The DOI for Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies is on the source record.
What is the PMID of Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies?
The PMID for Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies is on the source record.
What is the OpenAlex record for Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies?
The OpenAlex for Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies is on the source record.